AlphaCrest Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,494
Closed -$4.78M 576
2022
Q3
$4.78M Buy
25,494
+19,821
+349% +$4.26M 0.29% 28
2022
Q2
$1.14M Buy
5,673
+4,718
+494% +$1.11M 0.06% 605
2022
Q1
$288K Sell
955
-1,502
-61% -$439K 0.02% 1114
2021
Q4
$883K Buy
2,457
+1,557
+173% +$536K 0.03% 850
2021
Q3
$298K Buy
+900
New +$302K 0.02% 1108
2021
Q2
Sell
-10,467
Closed -$2.58M 1289
2021
Q1
$2.58M Buy
10,467
+5,640
+117% +$1.42M 0.14% 186
2020
Q4
$1.32M Sell
4,827
-3,624
-43% -$900K 0.11% 231
2020
Q3
$2M Buy
8,451
+6,936
+458% +$1.56M 0.22% 90
2020
Q2
$288K Sell
1,515
-1,704
-53% -$305K 0.05% 652
2020
Q1
$531K Sell
3,219
-159
-5% -$29.1K 0.06% 541
2019
Q4
$666K Buy
+3,378
New +$632K 0.05% 595
2019
Q3
Sell
-2,463
Closed -$431K 1287
2019
Q2
$431K Buy
+2,463
New +$422K 0.04% 752
2019
Q1
Sell
-3,000
Closed -$479K 888
2018
Q4
$479K Buy
+3,000
New +$508K 0.14% 257

Other funds holding ISRG

AlphaCrest Capital Management's ISRG Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Intuitive Surgical (ISRG) in Q4 2022, closing a stake of 25,494 shares — an estimated $4.78M sold.

AlphaCrest Capital Management first reported a position in ISRG in Q4 2018 and held it in 13 quarters. The position peaked at $4.78M in Q3 2022. 1,437 funds tracked by Wall St. Rank hold ISRG as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Intuitive Surgical position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 25,494 Intuitive Surgical shares in Q4 2022, an estimated $4.78M.
  • AlphaCrest Capital Management first reported a position in Intuitive Surgical in Q4 2018 and held it in 13 quarters.
  • AlphaCrest Capital Management's Intuitive Surgical position peaked at $4.78M in Q3 2022.
  • 1,437 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.